Keywords: Mild; Moderate; Asthma; Lebrikizumab; AE; adverse event; AQLQ(S); Standardised Asthma Quality of Life Questionnaire; ATA; anti-therapeutic antibodies; FeNO; fractional exhaled nitric oxide; FEV1; forced expiratory volume in 1â¯s; HLGT; high level group t
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ADT; antidepressant treatment; ANCOVA; analysis of covariance; ATRQ; Massachusetts General Hospital Antidepressant Treatment Response Questionnaire; BMI; body mass index; CGI-I; Clinical Global Impressions - Improvement; DSM-IV-TR; Diagnostic and Statis
Keywords: ANCOVA; Analysis of covariance; C-CASA; Columbia Classification Algorithm for Suicide Assessment; CGI-I; Clinical Global Impressions - Global Improvement; CGI-S; Clinical Global Impressions - Severity of Illness; CRT; Choice Reaction Time; C-SSRS; Col
Keywords: Acquired brain injury; Behavioural family intervention; Acceptance and Commitment Therapy; Randomised controlled trial; Parenting; AAABIQ; Acceptance and Action ABI Questionnaire; ABI; Acquired Brain Injury; ACT; Acceptance and Commitment Therapy; ASD; Au
Long-term effectiveness of aripiprazole once-monthly for schizophrenia is maintained in the QUALIFY extension study
Keywords: Aripiprazole once-monthly; Schizophrenia; Maintenance treatment; Quality of life; AE; adverse event; APTS; all-patients-treated set; AOM 400; aripiprazole once-monthly 400Â mg; CGI-S; Clinical Global Impressions-Severity; C-SSRS; Columbia Suicide Severity
Lumacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease homozygous for F508del-CFTR
Keywords: AE; adverse event; AESI; adverse event of special interest; ALT; alanine transaminase; AST; aspartate transaminase; BMI; body mass index; CF; cystic fibrosis; CFQ-R; Cystic Fibrosis Questionnaire-Revised; CI; confidence interval; IV; intravenous; IVA; i
Tiotropium Respimat Add-on Is Efficacious in Symptomatic Asthma, Independent of T2 Phenotype
Keywords: Allergy; Asthma; Tiotropium Respimat; T2 status; Eosinophil; IgE; Subgroup analysis; ACQ-7; 7-question Asthma Control Questionnaire; FEV1(0-3h); FEV1 within 3 hours of tiotropium plus maintenance therapy; HFA-MDI; Hydrofluoroalkane metered-dose inhaler; H
Pegvaliase for the treatment of phenylketonuria: A pivotal, double-blind randomized discontinuation Phase 3 clinical trial
Keywords: ACMG; American College of Medical Genetics and Genomics; ADHD RS-IV IA; Attention Deficit Hyperactivity Disorder Rating Scale IV, inattention subscore; AE; adverse event; ANCOVA; analysis of covariance; CANTAB; Cambridge Neuropsychological Test Automated
Symptoms and functioning with aripiprazole once-monthly injection as maintenance treatment for bipolar I disorder
Keywords: AOM 400; aripiprazole once-monthly 400Â mg; Brief QoL.BD; Brief Quality of Life in Bipolar Disorder Questionnaire; BP-I; bipolar I disorder; CGI-BP-C; Clinical Global Impressions-Bipolar version-change from preceding phase; CGI-BP-S; Clinical Global Impre
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial
Keywords: atopic dermatitis; fezakinumab; IL-22; placebo-controlled trial; moderate-to-severe AD; AD; atopic dermatitis; BSA; body surface area; BMI; body mass index; EASI; Eczema Area and Severity Index; IGA; Investigator Global Assessment; ITT; intention to treat
Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM-INSULIN trial
Keywords: Alirocumab; Diabetes; Insulin; LDL-C; ODYSSEY; PCSK9; AE; adverse event; Apo; apolipoprotein; ASCVD; atherosclerotic cardiovascular disease; CHD; coronary heart disease; CV; cardiovascular; CVD; cardiovascular disease; DM; diabetes mellitus; HDL-C; high-d
Glycaemic control and hypoglycaemia with insulin glargine 300 U/mL compared with glargine 100 U/mL in Japanese adults with type 2 diabetes using basal insulin plus oral anti-hyperglycaemic drugs (EDITION JP 2 randomised 12-month trial including 6-month ex
Keywords: Glycaemic control; Hypoglycaemia; Insulin glargine; Type 2 diabetes; AE; adverse event; ANCOVA; analysis of covariance; BL; baseline; BMI; body mass index; CI; confidence interval; FPG; fasting plasma glucose; Gla-100; glargine 100; Gla-300; glargine 300;
Quelle place pour la modélisation dans les essais cliniques en psychiatrie ?
Keywords: Modélisation; Pharmacocinétique; Pharmacodynamique; Nonmem; Régression non-linéaire à effets mixtes; LOCF; MMRM; Modeling; Pharmacokinetics; Pharmacodynamic; Nonmem; Non-linear mixed effects modeling; Last Observation Carried Forward;
Efficacy and safety of an adjunctive mGlu2 receptor positive allosteric modulator to a SSRI/SNRI in anxious depression
Keywords: MDD; major depressive disorder; SSRI; selective serotonin reuptake inhibitor; SNRI; serotonin-norepinephrine reuptake inhibitor; PAM; positive allosteric modulator; mGluR2; metabotropic glutamate 2 receptor; STAR*D; Sequenced Treatment Alternatives to Rel
Catechol-O-methyltransferase gene variants may associate with negative symptom response and plasma concentrations of prolactin in schizophrenia after amisulpride treatment
Keywords: AR1; autoregression of an order-1; COMT; catechol-O-methyltransferase; DSM-IV-TR; diagnostic and statistical manual of mental disorders, fourth edition, text revision; LD; linkage disequilibrium; MMRM; mixed model for repeated-measures; PANSS; positive an
Efficacy and safety of umeclidinium/vilanterol 62.5/25Â mcg and tiotropium 18Â mcg in chronic obstructive pulmonary disease: Results of a 24-week, randomized, controlled trial
Keywords: Long-acting bronchodilator; Umeclidinium; Vilanterol; AE; adverse event; CI; confidence interval; COPD; chronic obstructive pulmonary disease; DPI; Dry powder inhaler; FEV1; forced expiratory volume in one second; FP; fluticasone propionate; FVC; forced v
Long-Acting Bronchodilators and Arterial Stiffness in Patients With COPD
Keywords: AE; adverse event; AIx; augmentation index; aPWV; aortic pulse wave velocity; CVD; cardiovascular disease; FF/VI; fluticasone furoate/vilanterol; ICS; inhaled corticosteroid; ITT; intent-to-treat; LABA; long-acting β-agonist; LOCF; last observation carri
Sensitivity of individual items of the Positive and Negative Syndrome Scale (PANSS) and items subgroups to differentiate between placebo and drug treatment in schizophrenia
Keywords: PANSS; PANSS subscales; Antipsychotics; LOCF; MMRM; PKPD;
Duloxetine, Pregabalin, and Duloxetine Plus Gabapentin for Diabetic Peripheral Neuropathic Pain Management in Patients With Inadequate Pain Response to Gabapentin: An Open-Label, Randomized, Noninferiority Comparison
Keywords: ANCOVA; analysis of covariance; BOCF; baseline observation carried forward; BPI; Brief Pain Inventory; CI; confidence interval; DPNP; diabetic peripheral neuropathic pain; HbA1c; glycated hemoglobin; ITT; intent to treat; LOCF; last observation carried fo
Adjunctive lamotrigine therapy for patients with bipolar II depression partially responsive to mood stabilizers
Keywords: CANMAT; Canadian Network for Mood and Anxiety Treatments; CGI-BP-S; clinical global impressions-bipolar version-severity; MDC; mood disorders clinic; SCID-I; structured clinical interview for DSM-IV axis I; MMRM; mixed-effects model of repeated measuremen
A monoamine oxidase B gene variant and short-term antidepressant treatment response
Keywords: 5-HT; serotonin; 5-HTT; serotonin transporter; ANOVA; analysis of variance; bp; base-pair; CEU-CEPH; Utah residents with ancestry from northern and western Europe; CGI; Clinical Global Impressions Scale; CI; 95%-confidence interval; COMT; catechol-O-methy
Mixed model regression mapping for QTL detection in experimental crosses
Keywords: Mixed model; REML; ASReml; QTL mapping; MMRM